Ascendis Pharma A/S (ASND)
239.22
-2.87
(-1.19%)
USD |
NASDAQ |
Mar 03, 16:00
239.06
-0.16
(-0.06%)
After-Hours: 20:00
Ascendis Pharma Research and Development Expense (Annual) : 333.10M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Novo Nordisk A/S | 6.838B |
| Evaxion AS | 10.14M |
| DBV Technologies SA | 89.90M |
| Cellectis SA | 72.02M |
| Biodexa Pharmaceuticals Plc | 6.679M |